Weekly treatment with a combination of bortezomib and bendamustine in relapsed or refractory indolent non-Hodgkin lymphoma. Leukemia & lymphoma [Leuk Lymphoma] Journal article

Title	Weekly treatment with a combination of bortezomib and bendamustine in relapsed or refractory indolent non-Hodgkin lymphoma.
Author(s)	Moosmann P, Heizmann M, Kotrubczik N, Wernli M, Bargetzi M
Institution	Center of Oncology, Hematology, and Transfusion Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Source	Leuk Lymphoma 2009 Oct 1.
Language	ENG
Pub Type(s)	JOURNAL ARTICLE
PubMed ID	19860608

Advertise on this site.